Exact Mass: 443.0853

Exact Mass Matches: 443.0853

Found 12 metabolites which its exact mass value is equals to given mass value 443.0853, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

LY2874455

1H-Pyrazole-1-ethanol, 4-((1E)-2-(5-((1R)-1-(3,5-dichloro-4-pyridinyl)ethoxy)-1H-indazol-3-yl)ethenyl)-

C21H19Cl2N5O2 (443.0916)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor

   

Selinexor

3-{3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl}-N-(1,2-dihydropyrazin-2-ylidene)prop-2-enehydrazonate

C17H11F6N7O (443.0929)


   
   

CGP 54626 hydrochloride

CGP 54626 hydrochloride

C18H29Cl3NO3P (443.0951)


   

Selinexor

Selinexor

C17H11F6N7O (443.0929)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials, Guide to PHARMACOLOGY L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

OSI-930

OSI-930

C22H16F3N3O2S (443.0915)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

   

5-BroMo-7-[trans-4-(tert-butyldiMethylsilanyloxy)cyclohexyl]-2-chloro-7H-pyrrolo[2,3-d]pyriMidine

5-BroMo-7-[trans-4-(tert-butyldiMethylsilanyloxy)cyclohexyl]-2-chloro-7H-pyrrolo[2,3-d]pyriMidine

C18H27BrClN3OSi (443.0795)


   

(E)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N-(pyrazin-2-yl)acrylohydrazide

(E)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N-(pyrazin-2-yl)acrylohydrazide

C17H11F6N7O (443.0929)


   

N-(5-chloro-2,4-dimethoxyphenyl)-1-methyl-4-(4-morpholinylsulfonyl)-2-pyrrolecarboxamide

N-(5-chloro-2,4-dimethoxyphenyl)-1-methyl-4-(4-morpholinylsulfonyl)-2-pyrrolecarboxamide

C18H22ClN3O6S (443.0918)


   

N-[5-(1-azepanylsulfonyl)-2-chlorophenyl]-2-[(4-methyl-1,2,4-triazol-3-yl)thio]acetamide

N-[5-(1-azepanylsulfonyl)-2-chlorophenyl]-2-[(4-methyl-1,2,4-triazol-3-yl)thio]acetamide

C17H22ClN5O3S2 (443.0853)


   

4-{[(2s)-2-[(1-hydroxyethylidene)amino]-3-methoxy-3-oxopropyl]sulfanyl}phenazine-1,6-dicarboxylic acid

4-{[(2s)-2-[(1-hydroxyethylidene)amino]-3-methoxy-3-oxopropyl]sulfanyl}phenazine-1,6-dicarboxylic acid

C20H17N3O7S (443.0787)


   

4-({2-[(1-hydroxyethylidene)amino]-3-methoxy-3-oxopropyl}sulfanyl)phenazine-1,6-dicarboxylic acid

4-({2-[(1-hydroxyethylidene)amino]-3-methoxy-3-oxopropyl}sulfanyl)phenazine-1,6-dicarboxylic acid

C20H17N3O7S (443.0787)